Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-04-17

FDA Approved: AHZANTIVE — Supplemental Application (Valorum Biologics, LLC)

View source ↗

Summary

The FDA approved a supplemental application for AHZANTIVE (aflibercept-MRBB) from Valorum Biologics, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AHZANTIVE (AFLIBERCEPT-MRBB)

Snippet

SUPPL AP for AHZANTIVE (AFLIBERCEPT-MRBB)